Activated protein C resistance and adverse pregnancy outcome
- 31 July 1997
- journal article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 177 (1), 170-173
- https://doi.org/10.1016/s0002-9378(97)70457-5
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Resistance to activated protein C as a basis for venous thromboembolism associated with pregnancy and oral contraceptivesAmerican Journal of Obstetrics and Gynecology, 1995
- Identification of the same factor V gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein C.JCI Insight, 1994
- Linkage between inherited resistance to activated protein C and factor V gene mutation in venous thrombosisThe Lancet, 1994
- The Immunobiology and Obstetrical Consequences of Antiphospholipid AntibodiesObstetrical & Gynecological Survey, 1994
- Mutation in blood coagulation factor V associated with resistance to activated protein CNature, 1994
- Resistance to Activated Protein C as a Basis for Venous ThrombosisNew England Journal of Medicine, 1994
- Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia StudyThe Lancet, 1993
- Anticoagulant protein C pathway defective in majority of thrombophilic patients [see comments]Blood, 1993
- Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C.Proceedings of the National Academy of Sciences, 1993
- A standard of fetal growth for the united states of AmericaAmerican Journal of Obstetrics and Gynecology, 1976